CA2001737C - Immunoadjuvants liposomiques contenant il-2 - Google Patents
Immunoadjuvants liposomiques contenant il-2 Download PDFInfo
- Publication number
- CA2001737C CA2001737C CA 2001737 CA2001737A CA2001737C CA 2001737 C CA2001737 C CA 2001737C CA 2001737 CA2001737 CA 2001737 CA 2001737 A CA2001737 A CA 2001737A CA 2001737 C CA2001737 C CA 2001737C
- Authority
- CA
- Canada
- Prior art keywords
- vaccine
- liposomes
- antigen
- virus
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38277889A | 1989-07-19 | 1989-07-19 | |
US07/382,778 | 1989-07-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2001737A1 CA2001737A1 (fr) | 1991-01-19 |
CA2001737C true CA2001737C (fr) | 2007-07-10 |
Family
ID=23510383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2001737 Expired - Lifetime CA2001737C (fr) | 1989-07-19 | 1989-10-30 | Immunoadjuvants liposomiques contenant il-2 |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2001737C (fr) |
-
1989
- 1989-10-30 CA CA 2001737 patent/CA2001737C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2001737A1 (fr) | 1991-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5650152A (en) | Liposome immunoadjuvants containing IL-2 | |
Gregoriadis | Immunological adjuvants: a role for liposomes | |
US5340588A (en) | Liposphere carriers of vaccines | |
EP0440289B1 (fr) | Formulation de vaccin intranasal contenant des liposomes | |
US4053585A (en) | Immunological preparations | |
US7867480B1 (en) | Non-invasive vaccination through the skin | |
Davis et al. | Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics. | |
AU4221489A (en) | Affinity associated vaccine | |
US7767658B2 (en) | Vaccine composition | |
AU689505B2 (en) | Protein- or peptide-cochleate vaccines and methods of immunizing using the same | |
EP0356340B1 (fr) | Vaccin à affinité associée | |
US5897873A (en) | Affinity associated vaccine | |
CA2001737C (fr) | Immunoadjuvants liposomiques contenant il-2 | |
WO1990001947A1 (fr) | Vaccin a affinite associee | |
Gregoriadis et al. | The immunoadjuvant action of liposomes: role of structural characteristics | |
CA1334165C (fr) | Vaccin avec antigenes associes par affinite | |
Kersten et al. | Antigen Carriers: A Success Determining Factor for Subunit Vaccines? | |
Tan et al. | A Novel Positively-Charged Lipid 1, 2-Bis (Hexadecylcycloxy)-3-Trimethyl aminopropane (BisHOP) Enhances the Adjuvant Effect of Liposomes on Encapsulated Tetanus Toxoid | |
Gregoriadis | mmunoiogical adjuvants: a role for | |
MXPA06005486A (es) | Composicion de vacuna mezclada con una alquilfosfatidilcolina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKEC | Expiry (correction) |
Effective date: 20121202 |